B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 2.1 EUR 1.94% Market Closed
Market Cap: 42.7m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Net Margin
Bioretec Oy

-86.6%
Current
-147%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-86.6%
=
Net Income
-3.5m
/
Revenue
4.1m

Net Margin Across Competitors

Country FI
Market Cap 42.7m EUR
Net Margin
-87%
Country US
Market Cap 206.5B USD
Net Margin
14%
Country US
Market Cap 192.8B USD
Net Margin
29%
Country US
Market Cap 148.5B USD
Net Margin
16%
Country US
Market Cap 133.8B USD
Net Margin
11%
Country IE
Market Cap 111B USD
Net Margin
13%
Country US
Market Cap 65B USD
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Net Margin
8%
Country CN
Market Cap 326.2B CNY
Net Margin
33%
Country US
Market Cap 42.5B USD
Net Margin
74%
Country US
Market Cap 38.1B USD
Net Margin
9%
No Stocks Found

Bioretec Oy
Glance View

Market Cap
42.7m EUR
Industry
Health Care

Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.

BRETEC Intrinsic Value
3.71 EUR
Undervaluation 43%
Intrinsic Value
Price
B

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-86.6%
=
Net Income
-3.5m
/
Revenue
4.1m
What is the Net Margin of Bioretec Oy?

Based on Bioretec Oy's most recent financial statements, the company has Net Margin of -86.6%.